Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The overall burden of non-GI co-morbidity is a larger contributor to upper GI bleeding risk than aspirin or NSAID use alone, suggesting bleeding risk calculators should incorporate these factors.
Lanas et al. provide a potentially useful illustration of the balance of risks between upper gastrointestinal (GI) bleeding and cardiovascular disease to inform prescribing of aspirin.1 However, the tool assumes that the risk factors for bleeding are encompassed by a prior history of ulcer disease, Helicobacter pylori eradication and concomitant prescribing. This was derived from a paper that only assessed age, gender, history of peptic ulcer and nonsteroidal anti-inflammatory drugs (NSAIDs) as potential risk factors.2 Although there are doubtless a number of yet-to-be-discovered risk factors for GI bleeding, we have recently published a far more comprehensive analysis of both the recognised risk factors, and of non-GI co-morbidity. Our study has shown that aspirin and NSAID use were only a small part of the current story of risk factors for bleeding, and that in many cases the overall burden of co-morbidity was the largest contributor to bleeding risk.3 We found that the extra attributable risks for aspirin and NSAIDs were both around 3%. Although this increased to 4–5% when restricted to those with diagnosed peptic ulcers, the extra attributable fraction for non-GI co-morbidity was much higher at 19%. We believe therefore that the calculator proposed is unlikely to perform optimally when predicting the risk of bleeding, without revision to incorporate the role of other risk factors, including co-morbidities. We would caution against its adoption into clinical practise prior to validation in a population-based sample. Declaration of personal interests: TRC's wife is an employee of Takeda, and was previously employed by AstraZeneca. Declaration of funding interests: Colin Crooks is a research fellow and gastroenterology trainee supported by a Medical Research Council Population Health Scientist fellowship (grant number G0802427), Tim Card is a Clinical Associate Professor and Consultant Gastroenterologist, Joe West is a Clinical Associate Professor, Reader in Epidemiology, and Consultant Gastroenterologist supported by a University of Nottingham/Nottingham University Hospitals NHS Trust Senior Clinical Research fellowship. These funding bodies had no role in the writing of this letter.
No takes yet. Share an insight, caveat, or question.
Crooks et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: